Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Disease/Case Management of Patients Receiving ARANESP™ (Darbepoetin Alfa) to Treat the Anemia of Chronic Renal Insufficiency (CRI)

NCT00369733 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT00369733
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00369733 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Disease/Case Management of Patients Receiving ARANESP™ (Darbepoetin Alfa) to Treat the Anemia of Chronic Renal Insufficiency (CRI)
Lead sponsor
Amgen
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2002
Completion date
May 31, 2004
Enrollment
443 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, chronic renal insufficiency, kidney disease, pre-dialysis, pre-esrd